These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23085777)

  • 1. Treatment of Candida famata bloodstream infections: case series and review of the literature.
    Beyda ND; Chuang SH; Alam MJ; Shah DN; Ng TM; McCaskey L; Garey KW
    J Antimicrob Chemother; 2013 Feb; 68(2):438-43. PubMed ID: 23085777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida infections in non-neutropenic children after the neonatal period.
    Hacimustafaoglu M; Celebi S
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective evaluation of the cases with Candida famata fungemia in a burn unit].
    Turunç T; Demiroğlu YZ; Alişkan H; Colakoğlu S; Arslan H
    Mikrobiyol Bul; 2009 Jan; 43(1):71-6. PubMed ID: 19334382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes.
    Grim SA; Berger K; Teng C; Gupta S; Layden JE; Janda WM; Clark NM
    J Antimicrob Chemother; 2012 Mar; 67(3):707-14. PubMed ID: 22184469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010.
    Chen CY; Huang SY; Tsay W; Yao M; Tang JL; Ko BS; Chou WC; Tien HF; Hsueh PR
    Int J Antimicrob Agents; 2012 Dec; 40(6):533-8. PubMed ID: 23006521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections.
    Garnacho-Montero J; Díaz-Martín A; García-Cabrera E; Ruiz Pérez de Pipaón M; Hernández-Caballero C; Lepe-Jiménez JA
    J Antimicrob Chemother; 2013 Jan; 68(1):206-13. PubMed ID: 22945914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effectiveness of antifungal lock solutions on catheters infected with Candida species.
    Öncü S
    J Infect Chemother; 2011 Oct; 17(5):634-9. PubMed ID: 21327934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil.
    Purisco SU; Martins MA; Szeszs MW; Castro e Silva DM; Pukinskas SR; Bonfietti LX; Baez AA; Melhem MS
    FEMS Yeast Res; 2012 Dec; 12(8):890-6. PubMed ID: 22883021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidemia: species involved, virulence factors and antimycotic susceptibility.
    De Luca C; Guglielminetti M; Ferrario A; Calabr M; Casari E
    New Microbiol; 2012 Oct; 35(4):459-68. PubMed ID: 23109013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal catheter lock therapy for the management of a persistent Candida albicans bloodstream infection in an adult receiving hemodialysis.
    Paul DiMondi V; Townsend ML; Johnson M; Durkin M
    Pharmacotherapy; 2014 Jul; 34(7):e120-7. PubMed ID: 24782326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
    Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z
    New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006.
    Chen PL; Lo HJ; Wu CJ; Lee HC; Chang CM; Lee NY; Wang AH; Lin WL; Ko NY; Lee CC; Ko WC
    Mycoses; 2011 Jul; 54(4):e17-23. PubMed ID: 20028463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.
    Muñoz P; Sánchez-Somolinos M; Alcalá L; Rodríguez-Créixems M; Peláez T; Bouza E
    J Antimicrob Chemother; 2005 Feb; 55(2):188-93. PubMed ID: 15650001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent Candida conglobata bloodstream infection in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.
    Al-Sweih N; Ahmad S; Khan S; Khan Z; Joseph L; Vayalil S; Chandy R
    J Mycol Med; 2017 Jun; 27(2):271-276. PubMed ID: 28189376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter-related fungemia caused by Candida dubliniensis.
    Lai CC; Tsai HY; Chang TC; Hsueh PR
    J Microbiol Immunol Infect; 2013 Aug; 46(4):306-8. PubMed ID: 23246304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004].
    Eloy O; Blanc V; Pina P; Gaudart A; Bressolle ML; Plainvert C; Decousser JW; Pangon B; Allouch PY;
    Pathol Biol (Paris); 2006; 54(8-9):523-30. PubMed ID: 17029814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Our 2014 approach to candidaemia.
    Koehler P; Tacke D; Cornely OA
    Mycoses; 2014 Oct; 57(10):581-3. PubMed ID: 24863378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.